MAXIMILIANO VASQUEZ,KYUNG JIN KIM,WEI-MENG ZHAO,HANGIL PARK
申请号：
PT09825523
公开号：
PT2365828E
申请日:
2009.11.06
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
